Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Oct 10.
Published in final edited form as: Am J Hypertens. 2010 Sep 23;24(2):194–199. doi: 10.1038/ajh.2010.204

Prehypertension, Racial Prevalence and Association with Risk Factors: Analysis of The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study

Stephen P Glasser 1, Suzanne Judd 1, Jan Basile 2, Dan Lackland 3, Jewell Halanych 1, Mary Cushman 4, Ronald Prineas 5, Virginia Howard 1, George Howard 1
PMCID: PMC3468299  NIHMSID: NIHMS409258  PMID: 20864944

Abstract

Background

There are few available data on the epidemiology of prehypertension

Objective

To determine racial, clinical, and demographic differences in the prevalence of prehypertension and its cross-sectional association with vascular risk factors.

Methods

Cross-sectional analysis of 5553 prehypertensives, 20351 hypertensive’s, and 4246 non hypertensive participants (age ≥45), from a population-based national cohort study (REGARDS total population 30239, of whom 30150 had adequate blood pressure measurements) enrolled from January 2003-October 2007 with over-sampling from the southeastern Stroke Belt, and black individuals. Baseline data were collected using a combination of telephone interview and in-home evaluation. Prehypertension was defined according to JNC 7 guidelines.

Results

The prevalence of pre-hypertension was associated with age and black race (62.9% in blacks compared to 54.1% in whites). A higher prevalence of pre-hypertension was observed in obese individuals, self-reported heart disease; and, those with elevated hsCRP, diabetes, and microalbuminuria compared to those without these factors. Heavy alcohol consumption in white participants was associated with increased odds of pre-hypertension (OR = 1.32) but was even greater in black participants (OR=2.27).

Conclusion

The prevalence of prehypertension increased by age and African-American race. In addition, a higher prevalence of pre-hypertension was observed with elevated hsCRP, diabetes, microalbuminuria, and those with heavy alcohol consumption compared to those without these factors.

Keywords: prehypertension, risk factors, cardiovascular disease

Introduction

The Seventh Report of the Joint national Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) defined prehypertension (preHTN) as a blood pressure of 120-139 mmHg systolic and/or 80-89 mmHg diastolic, which in the past was called transient hypertension, borderline hypertension or high normal blood pressure. Although the terminology has changed, there is agreement that preHTN is a precursor of hypertension and that there is the potential for its association with an excess morbidity and death from cardiovascular disease (CVD).1 One study suggested that if preHTN were eliminated, that potentially 47% of all heart attacks might be prevented.2 There is also controversy concerning the potential cardiovascular risk associated with preHTN. This controversy is mostly centered on the wide variation in cardiovascular risk among this group; and, is dependant upon co-existing risk factors as has been suggested by Gu et al3 who found, after adjustment for risk factors, no association of preHTN with CVD mortality. Data from the 1999 and 2000 National Health and Nutrition Examination Survey (NHANES III) estimated that the prevalence of preHTN among adults in the United States was approximately 31 percent. 4 The prevalence of preHTN in NHANES III was higher among men than women (39 and 23 percent, respectively). In WHI, prevalence by race-ethnic groups were provided and ranged from 32-40%. WHI also reported an increased risk of myocardial infarction (MI), stroke, CVD death and other outcomes in the prehypertensive groups over 7.7 years of follow-up. 5 The Trial of Preventing Hypertension (TROPHY) provided evidence to support that the treatment of preHTN in reducing the development of hypertension. 6

Few data describe potential racial differences in the prevalence of preHTN, or racial differences in its association with risk factors and other clinical variables. Therefore, we addressed these questions in the Reasons for Geographic And Racial Differences in Stroke (REGARDS) cohort, by reporting the prevalence and risk factor profiles of participants with the diagnosis of preHTN. These analyses extend previous research by capitalizing on the large, geographically dispersed, race- and gender-balanced sample of the REGARDS cohort.

METHODS

Study Population

REGARDS is a national cohort of community dwelling individuals age 45 years or older, recruited with approximately equal representation of white and black, and male and female participants (n=30239). Twenty-one percent (20% was the original goal) of the sample was randomly selected from the “buckle” of the Stroke Belt (coastal plain region of North Carolina, South Carolina, and Georgia), 35% (30% goal) from the Stroke Belt states (remainder of North Carolina, South Carolina, and Georgia plus Alabama, Mississippi, Tennessee, Arkansas, and Louisiana), and the remaining 44% (50% was the goal) from the other 40 contiguous states. Individuals were identified from commercially available lists of residents, and recruited using an initial mailing followed by telephone contact. Defined according to standards recommended by Morton et al., the telephone response rate was 33% and the cooperation rate was 49% (similar to other epidemiological studies, the Multi-Ethnic Study of Atherosclerosis, MESA, for example with a 39.8% participation rate among those contacted and to whom the study was explained.). 7 In this cross-sectional analysis, 5553 prehypertensives, 20351 hypertensive’s, and 4246 non hypertensive participants were analyzed. (Figure 1)

Figure 1.

Figure 1

The Exclusionary Cascade representing the analysis population

Trained interviewers obtained demographic information and medical history using computer-assisted telephone interview (CATI). Consent was obtained verbally by telephone and subsequently in writing during a follow-up in-home visit 2-4 weeks after the telephone interview. Height, weight and blood pressure measurements were obtained from the in-person home visit. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were defined as the average of two measurements taken by a trained technician using a standard protocol and regularly tested aneroid sphygmomanometer, measured in the fasting state (except that there was no prohibition of coffee) after the participant was seated for 5 minutes. As reported in JNC 78 “At least two measurements should be made and the average recorded,” and this was the protocol used by REGARDS. Blood pressure quality control was monitored by central examination of digit preference and retraining of technicians took place as necessary. Participants were followed by telephone at six-month intervals for cognitive assessment and surveillance of medical events including potential stroke and myocardial infarction events. The study methods were reviewed and approved by all involved Institutional Review Boards. Additional methodological details are provided elsewhere. 9

Study recruitment ended in October of 2007 with a final cohort size of 30239. There was a total of 5553 with prehypertension, 522 of whom had a DBP of 80-89 but with a SBP of <120 mmHg; 2893 with DBP < 80 but with SBP of 120-139 mmHg; and, 2138 with DBP of 80-89 and SBP 120-139 mmHg.

Statistical Analysis

As part of our primary hypothesis, we sought to examine race as an a priori effect modifier. Categorical covariates of interest were race, geographic location (stroke belt, stoke buckle, or other), urban/rural location, income, education, sex, smoking, physical activity, alcohol use, prior history of CVD (self-reported, MI, vascular disease, or vascular intervention or EKG evidence of MI), self-reported stroke/TIA, and diabetes (defined as fasting glucose level >126 ml/dL, non-fasting glucose >200 ml/dL, or self-reported medication use for glucose control). Alcohol use was categorized as number of drinks per day (none, moderate defined as 1-7 drinks/week for women and 1-14 for men, heavy defined as >7 drinks/day for women and >14 for men). Physical activity level was defined by response to the question “How many times per week do you engage in intense physical activity, enough to work up a sweat?” categorized as none, 1-3 times, or 4 or more times per week. Body mass index (BMI) was determined as a function of measured height and weight. Urban/rural status was defined by residence on the basis of the percentage of the census track residing inside of urban areas/clusters; the status was rural if ≤25% urban, mixed between 25-75% urban, and urban if ≥75% urban. Smoking was categorized as never, current or past. Pearson’s chi-squared was used to obtain a p value to compare frequency distributions of pre-hypertension. We examined high sensitivity C reactive protein (hsCRP in mg/L), BMI, age, estimated GFR, and urinary albumin-creatinine ratio (ACR) as both continuous and categorical covariates. Microalbuminuria was defined as ACR greater than 17 mg/G for men and 25 mg/G for women. 10 We used cut points of 1.0 and 3.0 to create a three category variable for hsCRP and of 3.0 to create the dichotomous hsCRP variable.

Logistic regression (PROC LOGISTIC in SAS 9.1 Cary, NC) was used to calculate odds ratios for multivariable models. We first assessed the interaction between race and region and their association with prehypertension. This interaction p value was 0.0015. Therefore, we presented all results stratified by race. The covariates described above were tested as potential confounders in all models. We used backwards elimination to determine significant correlates of preHTN in the models.

Results

The total REGARDS cohort consists of 30239 individuals, of whom 30150 had blood pressure measures. Individuals with elevated SBP (6314) or DBP (602) or individuals using antihypertensive medication, both observed (12,818) and self-reported (617), were excluded. This left an analysis population of 9799 (Figure 1), of whom 5553 (51%,-17% of the 30150) individuals were prehypertensive (Table 1).

Table 1. Prevalence of pre-hypertension by demographic and socioeconomic characteristics.

n Blacks (n=2817)
 % of black subpopulation with
 pre-hypertension
n Whites (n=6982)
 % of white subpopulation with
 pre-hypertension

Total with pre-hypertension 1773 62.9 3780 54.1
Classification of pre-hypertension
SBP<120 mmHg and DBP≥80 mmHg 162 360
DBP < 80 mmHg and SBP≥120 mmHg 836 2057
SBP≥120 mmHg and DBP≥80 mmHg 775 1363
Gender
 Male 986 58.9 1790 47.4
 Female 787 69.1 1990 62.0
Region
 Stroke Belt 520 58.5 1328 55.6
 Stroke Buckle 309 63.3 780 51.3
 Non Belt 944 65.8 1672 54.4
Age group
 45–54 383 55.7 572 43.3
 55–64 773 63.9 1610 52.4
 65–74 459 66.9 1116 60.2
 75+ 158 69.6 482 65.8
Rural/urban (missing 3)
 <=25% Urban 186 62.2 932 54.2
 Mixed 25-75% Urban 88 61.9 491 64.0
 Urban 1499 63.2 2357 54.1
Income
 $20K 347 65.2 363 58.6
 $20K–$34K 450 61.9 755 58.4
 $35K–74K 536 62.3 1308 55.7
 $75+ 228 61.2 897 47.8
 Refused to report 212 65.8 457 54.1
Years of education (missing 6)
 <High school 253 67.8 220 65.5
 High school 468 63.8 851 51.0
 Some college 504 62.2 1031 56.0
 College+ 548 61.2 1678 50.7

Prehypertension defined as systolic blood pressure between 120 and 139 mmHg or diastolic blood pressure between 80 and 89 mmHg. Hypertensives were excluded from analysis.

Percentages refer to racial specific prevalences of pre-hypertension within each stratum of covariates. Example: 58.9% of black males have pre-hypertension compared to 47.4% of white males.

The prevalence (Table 1) of preHTN was greater with age in both black and white participants. The prevalence of preHTN differed by region and ranged between 51% for whites in the stroke buckle to 66% for black individuals living in the stroke belt (p=0.02). The prevalence of preHTN was higher in black participants across all age and gender strata, 58.9% of black males had preHTN while 47.4% of white males had preHTN (p<.001). We used multivariable logistic regression to further examine the racial disparity in the odds of preHTN (Figure 2). Except for low income, obesity, and diabetes, blacks had a greater odds of preHTN compared to whites in regards to gender, region of the country, age, smoking status, and years of education.

Figure 2.

Figure 2

A Forest plot of the odds ratios of prehypertension comparing black to white participants in the REGARD study. Models adjust for age, gender, income, and education.

We used multivariable logistic regression to describe the association of risk factors for preHTN stratified by race (Table 2). Participants who reported heavy drinking were more likely to have prehypertension than non drinkers. The magnitude of effect was greater in black participants than white participants (OR=2.27 and 1.32 respectively). In addition, moderate alcohol consumption in white participants was associated with a reduction in the odds of pre-hypertension (OR = 0.95) and was 1.08 in black participants (NS). In white participants, behaviors such as smoking and exercise were not associated with pre-hypertension. In contrast, for black participants we observed a marginally significant (p= 0.02) unexpected association where higher levels of exercise were associated with a higher odds of pre-hypertension, a finding that we feel is likely a type 1 error (i.e., spurious finding perhaps associated with multiple testing), or potentially inaccurate self-reporting of exercise frequency or a result of untested interactions. White participants with higher BMIs were at slightly higher odds of having preHTN (OR=1.71 vs 1.55 in black participants, p<0.001). Finally, while there was a significant (p < 0.05) positive association of pre-HTN with CVD and CVD risk factors (elevated hsCRP, stroke, heart disease, diabetes, cognitive dysfunction, microalbuminuria, and chronic kidney disease), there were no apparent racial differences in their cross-sectional association with pre-HTN.

Table 2. Association of pre-hypertension with demographic, socioeconomic and lifestyle factors stratified by race.

Whites Blacks

Model 1w Model 2w Model1b Model 2b

OR p OR p OR p OR p
Region (Non belt is reference)
 Belt 1.05 (0.93, 1.18) 1.06 (0.95, 1.19) 0.78 (0.65, 0.95) 0.77 (0.65, 0.94)
 Buckle 0.89 (0.78, 1.02) 0.91 (0.79, 1.03) 0.91 (0.72, 1.14) 0.90 (0.72, 1.13)
Age (10 yrs) 1.43 (1.35, 1.53) 1.48 (1.40, 1.57) 1.30 (1.18, 1.44) 1.32 (1.21, 1.45)
Male 1.75 (1.56, 1.93) 1.73 (1.56, 1.92) 1.78 (1.49, 2.13) 1.86 (1.56, 2.21)
BMI (5 kg/m2) 1.74 (1.56, 1.93) 1.73 (1.65, 1.85) 1.57 (1.45, 1.71) 1.58 (1.45, 1.71)
Income
 $20K 1.26 (1.01, 1.56) 0.95 (0.69, 1.31)
 $20K–$34K 1.24 (1.04, 1.46) 1.05 (0.78, 1.42)
 $35K–74K 1.16 (1.02, 1.33) 1.01 (0.77, 1.33)
 Refused 1.19 (0.98, 1.42) 1.17 (0.82, 1.67)
Years of education (missing 6)
 <High school 1.65 (1.26, 2.15) 1.67 (1.30, 2.15) 1.09 (0.81, 1.46)
 High school 1.22 (1.06, 1.41) 1.27 (1.11, 1.45) 1.05 (0.83, 1.33)
 Some college 1.16 (1.02, 1.32) 1.21 (1.06, 1.36) 1.01 (0.81, 1.26)
Alcohol Consumption
 Moderate (0-7 women, 0-14 men) 0.96 (0.86, 1.08) 0.95 (0.85, 1.06) 1.07 (0.88, 1.30) 1.08 (0.91, 1.30)
 Heavy (7+ women 14+ men) 1.35 (1.06,1.72) 1.32 (1.04,1.66) 2.20 (1.25, 3.80) 2.27 (1.32, 3.94)
Exercise (4+ times per week is
reference)
 None 0.94 (0.82, 1.07) 0.74 (0.60, 0.92) 0.74 (0.61, 0.92)
 1 to 3 times 1.04 (0.93, 1.17) 0.88 (0.72, 1.07) 0.87 (0.72, 1.06)
Smoke (Never is reference)
 Current 0.94 (0.80, 1.10) 1.09 (0.86, 1.37)
 Past 1.06 (0.95, 1.19) 1.21 (0.99, 1.46)
Pre-existing diabetes 0.87 (0.72, 1.05) 1.02 (0.80, 1.30)
eGFR<60 1.26 (1.02, 1.55) 1.11 (0.81, 1.53)

Wald Chi square

Model 1w is the full model and controls for region of residence, age, gender, BMI as a continuous variable, income, education, exercise, smoking status, and alcohol consumption

Model 2w is the most parsimonious model and controls for region of residence, age, gender, BMI as a continuous variable, education, and alcohol consumption. Income, exercise, and smoking status were not statistically significant covariates.

Model 1b is the full model and controls for region of residence, age, gender, BMI as a continuous variable, income, education, exercise, smoking status, and alcohol consumption.

Model 2b is the most parsimonious model and controls for region of residence, age, gender, BMI as a continuous variable, education, and alcohol consumption. Income, exercise, smoking status, and education were not statistically significant covariates.

DISCUSSION

There has been controversy surrounding the classification of BP termed preHTN, mostly centered upon the wide variation in risk among this group. While accumulating literature suggests that preHTN is associated with adverse clinical outcomes, the epidemiology of preHTN has been less well described. An analysis of a large cohort of men and women from the REGARDS Study helps to fill this gap in knowledge. Of 9799 non-hypertensive individuals, 51% (17% of the entire REGARDS cohort) were defined as demonstrating preHTN (including 522 of whom had DBP>80 but SBP<120; 2893 had DBP<80 but SBP≥120; and, 2138 with a DBP of 80-89 and a SBP of 120-139 mmHg). The prevalence of pre-hypertension has been reported to be about 30% of the adult US population.1 The overall prevalence found in our study was 17%, however, excluding subjects with hypertension it was 51%. We observed that the prevalence of pre-hypertension was higher by age and black race (62.9% compared to 54.1% in whites), and a higher prevalence of pre-hypertension was observed in obese individuals, self-reported heart disease; and, those with elevated hsCRP, diabetes, and microalbuminuria compared to those without these factors. Heavy alcohol consumption in white participants was associated with an increased odds of pre-hypertension (OR = 1.32) but was even greater in black participants (OR=2.27 p<.03). Some of these observations are in concert with prior reported studies. For example, in a retrospective analysis from the San Antonio Heart Study, it was found that at baseline, prehypertension was associated with male gender, higher BMI, and measures of impaired glucose intolerance. In terms of race/ethnic variables, NHANES III found no difference in the prevalence between Non-Hispanic whites, Non-Hispanic blacks, Mexican Americans or other (all had a prevalence of about 31%), compared to our analytic sample where the African American prevalence of preHTN was higher than whites.

The lifetime risk of developing hypertension approaches 90%, however, the etiology of hypertension remains elusive for the vast majority.11 Howard et al reported that the prevalence of hypertension was related to the duration and age at exposure to the stroke belt, however, neither they nor we analyzed the prevalence of prehypertension by those variables.12 The complications of long standing hypertension are well known and relate to arterial disease with clinical manifestations in the heart, brain and kidney. However, the paradigm of elevated blood pressure resulting in vasculopathy continues to be challenged. Rather than hypertension resulting in altered vascular structure and function, it appears that changes in vascular integrity (structure) precede, and may be causal, in the development of elevated blood pressure with resultant hypertension that ultimately leads to clinical events. 13 Alterations in cardiovascular structure and function that have been shown to precede the finding of elevated blood pressure include the occurrence of left ventricular hypertrophy in children and young adults of hypertensive parents, 14 although one cannot rule out the role of blood pressure in causing cardiovascular remodeling in studies where only resting, occasional measurements of blood pressure are made; diastolic filling abnormalities in normotensive individuals predisposed to hypertension; 15 endothelial dysfunction as a precursor to the finding of hypertension; 16 and increased arterial stiffness in normotensive subjects predisposed to develop hypertension. 17 Recently it has been reported that in confirmed prehypertensive subjects, intimal-medial thickness is increased in the common carotid artery when compared to subjects who remain normotensive. 18 It was also found in an analysis of subjects from The Bogalusa Heart Study that preHTN prevalence was higher among men than women and among black compared to white participants; and, that compared to normotensives, those with preHTN had higher left ventricular (LV) mass index, LV diameter, and carotid artery intima-media thickness. 19 If changes in vascular integrity precede the development of hypertension, preHTN could fit well into the natural history of this evolution. In contrast, Tomiyama et al pointed out that baseline preHTN BP was not an adequate predictor of the development of hypertension, although as they hypothesized that the rather short-term follow-up was a possible explanation for the weak association. 20

Limitations

The REGARDS study is subject to several limitations. Some risk factors were based on self report (although this is common to many epidemiologic studies), and individuals without telephones were necessarily excluded from selection into the study population. These excluded individuals may be of lower socioeconomic status and, therefore, may have different BP and risk factor profiles than those included in this analysis. Finally, participant BP was measured on a single occasion albeit by standard protocol.

In conclusion, we have characterized the cross-sectional associations of prehypertension with a number of lifestyle, geographic, and demographic factors in order to better understand the epidemiology of this potential precursor of clinical cardiovascular disease. PreHTN is common (51% of the non-hypertensive group), and is more likely to be present in those at risk for or with manifest vascular disease. We found that a higher prevalence of pre-hypertension was observed with elevated hsCRP, diabetes, heavy alcohol consumption, and microalbuminuria compared to those without these factors. Longitudinal studies are necessary to determine if BP in the prehypertensive range alone (i.e. in the absence of other risk factors) is a sufficient risk predictor for future CVD.

Acknowledgements

This research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data.2 The authors acknowledge the participating investigators and institutions for their valuable contributions: The University of Alabama at Birmingham, Birmingham, Alabama (Study PI, Statistical and Data Coordinating Center, Survey Research Unit): George Howard DrPH, Leslie McClure PhD, Virginia Howard PhD, Libby Wagner MA, Virginia Wadley PhD, Rodney Go PhD, Monika Safford MD, Ella Temple PhD, Margaret Stewart MSPH, J. David Rhodes BSN; University of Vermont (Central Laboratory): Mary Cushman MD; Wake Forest University (ECG Reading Center): Ron Prineas MD, PhD; Alabama Neurological Institute (Stroke Validation Center, Medical Monitoring): Camilo Gomez MD, Susana Bowling MD; University of Arkansas for Medical Sciences (Survey Methodology): LeaVonne Pulley PhD; University of Cincinnati (Clinical Neuroepidemiology): Brett Kissela MD, Dawn Kleindorfer MD; Examination Management Services, Incorporated (In-Person Visits): Andra Graham; Medical University of South Carolina (Migration Analysis Center): Daniel Lackland DrPH; Indiana University School of Medicine (Neuropsychology Center): Frederick Unverzagt PhD; National Institute of Neurological Disorders and Stroke, National Institutes of Health (funding agency): Claudia Moy PhD.

Footnotes

Conflict of Interest Statement

Stephen P Glasser: NONE

Suzanne Judd: NONE

Jan Basile: NONE

Dan Lackland: NONE

Jewell Halanych: NONE

Mary Cushman: NONE

Ronald Prineas: NONE

Virginia Howard: NONE

George Howard: NONE

References

  • 1.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560–2572. doi: 10.1001/jama.289.19.2560. [DOI] [PubMed] [Google Scholar]
  • 2.Qureshi A, Suri MFK, Kirmani JF, Divani AA, Mohammad Y. Prehypertension triples heart attack risk. Health and Medicine. ScienceDaily. from http://www.sciencedaily.com/releases/2005/08/050805110759.htm.
  • 3.Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol. 2008 Apr;18(4):302–309. doi: 10.1016/j.annepidem.2007.11.013. [DOI] [PubMed] [Google Scholar]
  • 4.Kaplan N, Rose B. Prehypertension and borderline hypertension. Up to date. 2007 http://www.uptodate.com.
  • 5.Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR. Prehypertension and cardiovascular disease risk in the Women’s Health Initiative. Circulation. 2007 Feb 20;115(7):855–860. doi: 10.1161/CIRCULATIONAHA.106.656850. [DOI] [PubMed] [Google Scholar]
  • 6.Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. The New England journal of medicine. 2006 Apr 20;354(16):1685–1697. doi: 10.1056/NEJMoa060838. [DOI] [PubMed] [Google Scholar]
  • 7.Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. American journal of epidemiology. 2006 Feb 1;163(3):197–203. doi: 10.1093/aje/kwj036. [DOI] [PubMed] [Google Scholar]
  • 8.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206–1252. doi: 10.1161/01.HYP.0000107251.49515.c2. [DOI] [PubMed] [Google Scholar]
  • 9.Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25(3):135–143. doi: 10.1159/000086678. [DOI] [PubMed] [Google Scholar]
  • 10.Derhaschnig U, Kittler H, Woisetschlager C, Bur A, Herkner H, Hirschl MM. Microalbumin measurement alone or calculation of the albumin/creatinine ratio for the screening of hypertension patients? Nephrol Dial Transplant. 2002 Jan;17(1):81–85. doi: 10.1093/ndt/17.1.81. [DOI] [PubMed] [Google Scholar]
  • 11.Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001 Nov 17;358(9294):1682–1686. doi: 10.1016/S0140-6736(01)06710-1. [DOI] [PubMed] [Google Scholar]
  • 12.Howard VJ, Woolson RF, Egan BM, Nicholas JS, Adams RJ, Howard G, Lackland DT. Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens. 2010 Jan-Feb;4(1):32–41. doi: 10.1016/j.jash.2010.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Glasser SP, Arnett DK. Vascular stiffness and the “chicken-or-the-egg” question. Hypertension. 2008 Feb;51(2):177–178. doi: 10.1161/HYPERTENSIONAHA.107.098830. [DOI] [PubMed] [Google Scholar]
  • 14.Radice M, Alli C, Avanzini F, Di Tullio M, Mariotti G, Taioli E, Zussino A, Folli G. Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. American heart journal. 1986 Jan;111(1):115–120. doi: 10.1016/0002-8703(86)90562-4. [DOI] [PubMed] [Google Scholar]
  • 15.Weber MA, Smith DH, Neutel JM, Graettinger WF. Arterial properties of early hypertension. Journal of human hypertension. 1991 Oct;5(5):417–423. [PubMed] [Google Scholar]
  • 16.Weber MA. Treatment Strategies in Hypertension. Symposia Specialists; Miami: 1981. [Google Scholar]
  • 17.Graettinger WF. Proceedings of the American Society of Hypertension; Paper presented at: American Society of Hypertension, Annual Scientific Meetings; N.Y. 1987. [Google Scholar]
  • 18.Femia R, Kozakova M, Nannipieri M, Gonzales-Villalpando C, Stern MP, Haffner SM, Ferrannini E. Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression. Arteriosclerosis, thrombosis, and vascular biology. 2007 Oct;27(10):2244–2249. doi: 10.1161/ATVBAHA.107.149641. [DOI] [PubMed] [Google Scholar]
  • 19.Toprak A, Wang H, Chen W, Paul T, Ruan L, Srinivasan S, Berenson G. Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. Journal of hypertension. 2009 Feb;27(2):243–250. doi: 10.1097/hjh.0b013e32831aeee3. [DOI] [PubMed] [Google Scholar]
  • 20.Tomiyama H, Matsumoto C, Yamada J, Yoshida M, Odaira M, Shiina K, Nagata M, Yamashina A. Predictors of progression from prehypertension to hypertension in Japanese men. Am J Hypertens. 2009 Jun;22(6):630–636. doi: 10.1038/ajh.2009.49. [DOI] [PubMed] [Google Scholar]

RESOURCES